Spots Global Cancer Trial Database for A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Official Title: A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Study ID: NCT04574284
Conditions
Study Description
Brief Summary: This is a study to evaluate the efficacy and safety of TQB2450 injection or combined with anlotinib hydrochloride capsule in the treatment of recurrent or metastatic advanced endometrial cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Anhui Provincial Hospital, Hefei, Anhui, China
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, China
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
Beijing Luhe Hospital Capital Medical University, Beijing, Beijing, China
Chongqing University Cancer Hospital, Chongqing, Chongqing, China
Gansu Provincial Hospital, Lanzhou, Gansu, China
Lanzhou University Second Hospital, Lanzhou, Gansu, China
Gansu Province Maternity and Chid-care Hospital, Lanzhou, Gansu, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Hunan Cancer Hospital, Changsha, Hunan, China
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
Liaoning Cancer Hospital, Shenyang, Liaoning, China
Binzhou Medical University Hospital, Binzhou, Shandong, China
Linyi Cancer Hospital, Linyi, Shandong, China
Qingdao Central Hospital, Qingdao, Shandong, China
Weifang People's Hospital, Weifang, Shandong, China
Yantai Yuhuangding Hospital, Yantai, Shandong, China
Obstetrics & Gynecology Hospital of Fudan University, Shanghai, Shanghai, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Xi'an People's Hospital, Xi'an, Shanxi, China
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, Tianjin, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region, China
The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
